Nov. 26, 2024 — Researchers have developed a new method called MoPEDE, which has the potential to improve epilepsy treatment. The method combines brain measurements with genetic analyses ...

LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in ...

OLE data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent AE safety profile suggesting ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, taking place December 6-10 in ...

blood no longer reaches the brain - he explains - consciousness is lost and there can be small clonic jerks in the limbs, ...

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, provided a business ...

LSU football wide receiver CJ Daniels has been inspired by the way his mom manages epilepsy, and he wants to spread awareness ...

By replicating the EEG and multi-unit activity (MUA) structure of a tonic–clonic seizure and comparing it with real MUA data, we validate the model’s underlying assumption: the transition from tonic ...

A person with epilepsy may qualify for disability benefits if it affects income, impairs physical, mental, or social functioning, or if certain types of seizures persist despite treatment.